Aims and Scope

Aims and Scope

Aims of the Journal

The Current Research Journal of Pharmaceutical and Allied Sciences (CRJPAS) aims to provide a scholarly platform for the publication and dissemination of research addressing fundamental, experimental, and applied aspects of pharmaceutical sciences.

The journal seeks to strengthen the relationship between pharmaceutical research, biomedical innovation, drug development, therapeutic applications, and evidence-based healthcare. Particular emphasis is placed on scientific originality, methodological robustness, research significance, and the potential contribution of submitted work to the advancement of pharmaceutical knowledge.

CRJPAS welcomes interdisciplinary studies that integrate pharmaceutical chemistry, pharmacology, drug delivery, biotechnology, biomedical sciences, and related fields, provided that they demonstrate a clear and substantive connection to pharmaceutical science.

Scope of the Journal

The journal considers research within the following principal subject areas.

Pharmaceutical Chemistry and Drug Discovery

Pharmaceutical and medicinal chemistry; drug design and molecular optimization; computational drug discovery; structure–activity relationships; pharmaceutical synthesis; bioactive compounds; analytical characterization; and novel therapeutic candidates.

Pharmaceutics and Drug Delivery

Pharmaceutical formulation development; drug delivery systems; pharmacokinetics and biopharmaceutics; pharmaceutical nanotechnology; controlled and targeted drug delivery; pharmaceutical excipients; dosage-form development; and formulation stability.

Pharmacology and Toxicology

Experimental pharmacology; molecular and cellular pharmacology; therapeutic mechanisms; drug–receptor interactions; pharmacodynamics; toxicological evaluation; preclinical safety; adverse drug reactions; and pharmacological assessment of therapeutic agents.

Pharmacognosy and Natural Products

Natural-product drug discovery; medicinal plants; phytochemistry; pharmacognostic evaluation; biologically active natural compounds; pharmacological investigation of plant-derived substances; and standardization of herbal pharmaceutical preparations.

Pharmaceutical Biotechnology

Biopharmaceutical development; recombinant pharmaceutical products; therapeutic proteins; biotechnology-based drug production; molecular biotechnology; biomolecular drug targets; and emerging biological approaches to pharmaceutical innovation.

Clinical and Translational Pharmaceutical Research

Clinical pharmacology; clinical pharmacy; pharmacovigilance; drug utilization; pharmacoepidemiology; medication safety; evidence-based pharmacotherapy; pharmaceutical care; and translational studies with direct relevance to pharmaceutical science.

Pharmaceutical Analysis and Quality Assurance

Analytical method development and validation; pharmaceutical quality control; stability testing; impurity profiling; pharmaceutical microbiology; pharmaceutical manufacturing quality; and regulatory aspects of medicinal products.

Interdisciplinary and Emerging Research

Interdisciplinary research combining pharmaceutical sciences with biomaterials, bioinformatics, molecular modeling, biomedical engineering, artificial intelligence in drug development, and other emerging technologies relevant to pharmaceutical discovery or healthcare.

Types of Manuscripts

Subject to the journal's approved article-category policies, CRJPAS may consider:

  • Original Research Articles

  • Review Articles

  • Systematic Reviews and Meta-Analyses

  • Short Communications

  • Methodological Research Articles

  • Relevant Case Reports or Case Studies

  • Scientific Perspectives and Editorial Contributions

Scope Limitations

Studies that fall entirely outside pharmaceutical and related biomedical sciences, or that lack a clearly demonstrated pharmaceutical relevance, are not considered suitable for publication.

Manuscripts must demonstrate an identifiable scientific contribution. Purely descriptive studies without sufficient methodological rigor, unsupported conclusions, and work lacking originality or relevance may be declined during initial editorial assessment.

Research Quality and Ethical Requirements

Research involving human participants, animals, biological materials, or clinical interventions must comply with applicable ethical and regulatory requirements. Authors are expected to report study design, methods, results, limitations, ethical approval, funding, and potential conflicts of interest transparently.

The journal encourages the use of recognized research reporting guidelines, including CONSORT, PRISMA, STROBE, ARRIVE, and other discipline-appropriate frameworks.

CRJPAS aims to support the dissemination of credible scientific evidence that advances pharmaceutical research and its responsible application to human health.